Vesalio
Founded 2017 · 65 employees on LinkedIn · 1 known investors
Find your way into Vesalio
Sign up to see every warm intro you have to Vesalio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vesalio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vesalio develops stroke treatment technology, specifically devices and systems for endovascular neurosurgical interventions to treat acute ischemic and hemorrhagic stroke. The company serves hospitals and neurosurgeons seeking advanced treatment options.
Founders & leadership
Vesalio was founded in 2017 by Arthur J. Ulm.
AJ

Arthur J. UlmCTO/Founder/Board Member
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountClass A financing roundJul 2021
Solas BioVentures (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Vesalio do?
- Vesalio develops stroke treatment technology, specifically devices and systems for endovascular neurosurgical interventions to treat acute ischemic and hemorrhagic stroke. The company serves hospitals and neurosurgeons seeking advanced treatment options.
- Who founded Vesalio?
- Vesalio was founded by Arthur J. Ulm in 2017.
- Who are Vesalio's investors?
- Vesalio's investors include Solas BioVentures.

